Cargando…

The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial

OBJECTIVES: To evaluate the immunogenicity of an extended interval regimen of BNT162b2 among healthy school-age children. METHODS: A randomized-control trial conducted among healthy Thai children aged 5-11 years. Participants received two doses of BNT162b2 with an 8-week (extended dosing) vs 3-week...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chantasrisawad, Napaporn, Techasaensiri, Chonnamet, Kosalaraksa, Pope, Phongsamart, Wanatpreeya, Tangsathapornpong, Auchara, Jaru-Ampornpan, Peera, Sophonphan, Jiratchaya, Suntarattiwong, Piyarat, Puthanakit, Thanyawee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011807/ https://www.ncbi.nlm.nih.gov/pubmed/36841501 http://dx.doi.org/10.1016/j.ijid.2023.02.017

Ejemplares similares

Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases
por: Chantasrisawad, Napaporn, et al.
Publicado: (2022)

Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster
por: Chantasrisawad, Napaporn, et al.
Publicado: (2022)

Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance
por: Nantanee, Rapisa, et al.
Publicado: (2023)

Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents
por: Puthanakit, Thanyawee, et al.
Publicado: (2022)

Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents
por: Puthanakit, Thanyawee, et al.
Publicado: (2022)

A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222
por: Nantanee, Rapisa, et al.
Publicado: (2022)

A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
por: Nanthapisal, Sira, et al.
Publicado: (2022)

Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers
por: Jantarabenjakul, Watsamon, et al.
Publicado: (2022)

Low Measles Seropositivity Rate among Thai Adolescents in the Thai National Immunization Program
por: Puthanakit, Thanyawee, et al.
Publicado: (2022)

Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi‐centre 48‐week efficacy and safety study in Thailand
por: Phongsamart, Wanatpreeya, et al.
Publicado: (2022)

Immunogenicity of BNT162b2 Vaccination against SARS-CoV-2 Omicron Variant and Attitudes toward a COVID-19 Booster Dose among Healthy Thai Adolescents
por: Assavavongwaikit, Pavinee, et al.
Publicado: (2022)

Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac
por: Nantanee, Rapisa, et al.
Publicado: (2022)

Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study
por: Phongsamart, Wanatpreeya, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy
por: Sudjaritruk, Tavitiya, et al.
Publicado: (2019)

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
por: Tangsathapornpong, Auchara, et al.
Publicado: (2023)

Clinical outcomes of pediatric COVID-19 in a tertiary care center in Bangkok, Thailand
por: Anugulruengkitt, Suvaporn, et al.
Publicado: (2021)

High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
por: Puthanakit, Thanyawee, et al.
Publicado: (2012)

Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand
por: Aikphaibul, Puneyavee, et al.
Publicado: (2020)

Nucleocapsid proteins from other swine enteric coronaviruses differentially modulate PEDV replication
por: Sungsuwan, Suttipun, et al.
Publicado: (2020)

Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study
por: Techasaensiri, Chonnamet, et al.
Publicado: (2021)

Autoimmune Hepatitis Triggered by COVID-19 Vaccine: The First Case From Inactivated Vaccine
por: Mekritthikrai, Krittaya, et al.
Publicado: (2022)

Growth enhancement of porcine epidemic diarrhea virus (PEDV) in Vero E6 cells expressing PEDV nucleocapsid protein
por: Liwnaree, Benjamas, et al.
Publicado: (2019)

Zinc-finger antiviral protein-mediated inhibition of porcine epidemic diarrhea virus growth is antagonized by the coronaviral nucleocapsid protein
por: Sungsuwan, Suttipun, et al.
Publicado: (2022)

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children
por: Bunupuradah, Torsak, et al.
Publicado: (2015)

BNT162b2 Protection against the Omicron Variant in Children and Adolescents
por: Price, Ashley M., et al.
Publicado: (2022)

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
por: Cele, Sandile, et al.
Publicado: (2021)

Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants
por: Lokanuwatsatien, Tananya, et al.
Publicado: (2023)

Prevalence, risk factors, and vaccine effectiveness of COVID-19 infection in thai children, adolescents, and young adults in the omicron era
por: Chaiyakulsil, Chanapai, et al.
Publicado: (2023)

Dengue amid COVID-19 pandemic
por: Tangsathapornpong, Auchara, et al.
Publicado: (2023)

PEDV ORF3 Independently Regulates IκB Kinase β-Mediated NF-κB and IFN-β Promoter Activities
por: Kaewborisuth, Challika, et al.
Publicado: (2020)

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
por: Collie, Shirley, et al.
Publicado: (2021)

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel
por: Bar-On, Yinon M., et al.
Publicado: (2022)

Temporal trend of drug-resistant tuberculosis among Thai children during 2006–2021
por: Jantarabenjakul, Watsamon, et al.
Publicado: (2022)

Low risk of neurodevelopmental impairment among perinatally acquired HIV‐infected preschool children who received early antiretroviral treatment in Thailand
por: Jantarabenjakul, Watsamon, et al.
Publicado: (2019)

Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency
por: Bunupuradah, Torsak, et al.
Publicado: (2012)

Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantation
por: Peled, Yael, et al.
Publicado: (2022)

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa
por: Collie, Shirley, et al.
Publicado: (2022)

Immunogenicity of an mRNA-Based COVID-19 Vaccine among Adolescents with Obesity or Liver Transplants
por: Tubjaroen, Chomchanat, et al.
Publicado: (2022)

A Comparison of Cefditoren Pivoxil 8-12 mg/kg/day and Cefditoren Pivoxil 16-20 mg/kg/day in Treatment of Children With Acute Presumed Bacterial Rhinosinusitis: A Prospective, Randomized, Investigator-Blinded, Parallel-Group Study
por: Poachanukoon, Orapan, et al.
Publicado: (2015)

Comparing Interferon-Gamma Release Assays to Tuberculin Skin Test in Thai Children with Tuberculosis Exposure
por: Tieu, Hong-Van, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nnoe0142t8nmpstbnbg1lekllh